share_log

AbbVie | 4: Statement of changes in beneficial ownership of securities-Director Davis Jennifer L.

AbbVie | 4: Statement of changes in beneficial ownership of securities-Director Davis Jennifer L.

艾伯维公司 | 4：持股变动声明-董事 Davis Jennifer L.
美股sec公告 ·  05/07 20:21
Moomoo AI 已提取核心信息
On May 3, 2024, Jennifer L. Davis, associated with AbbVie Inc. [ABBV], was granted 1,322 shares of common stock at no cost. The transaction, which was completed on the same day, increased Davis's direct holdings in the company to a total of 1,322 shares. The shares granted are classified as direct ownership with a par value of $0.01 each. Following the transaction, the total value of Davis's direct holdings in AbbVie has not been disclosed.
On May 3, 2024, Jennifer L. Davis, associated with AbbVie Inc. [ABBV], was granted 1,322 shares of common stock at no cost. The transaction, which was completed on the same day, increased Davis's direct holdings in the company to a total of 1,322 shares. The shares granted are classified as direct ownership with a par value of $0.01 each. Following the transaction, the total value of Davis's direct holdings in AbbVie has not been disclosed.
2024 年 5 月 3 日，与艾伯维公司 [ABBV] 关联的詹妮弗·戴维斯免费获得了 1,322 股普通股。该交易于当天完成，使戴维斯在该公司的直接持股量增加到1,322股。授予的股份被归类为直接所有权，每股面值为0.01美元。交易完成后，戴维斯直接持有的艾伯维的总价值尚未披露。
2024 年 5 月 3 日，与艾伯维公司 [ABBV] 关联的詹妮弗·戴维斯免费获得了 1,322 股普通股。该交易于当天完成，使戴维斯在该公司的直接持股量增加到1,322股。授予的股份被归类为直接所有权，每股面值为0.01美元。交易完成后，戴维斯直接持有的艾伯维的总价值尚未披露。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息